Watson Sues FDA for Failing to Grant Shared Exclusivity for Actos Generic

Drug Industry Daily
A A
Watson Pharmaceuticals is suing the FDA after it failed to grant the company shared exclusivity on a generic of Type 2 diabetes drug Actos.

To View This Article:

Login

Subscribe To Drug Industry Daily